1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. GLENMARK PHARMACEUTICALS LTD.
Glenmark Pharmaceuticals Ltd. NSE: GLENMARK | BSE: 532296
Mid-range Performer
Download real time
2004.40 85.60 (4.46%)
57.15% Gain from 52W Low
1.4M
NSE+BSE Volume

NSE 03 Sep, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
Product Launch
Glenmark to launch bioequivalent of Eisai's Halaven injection in US, with annual sales of $66.3 mn See details


Glenmark Pharmaceuticals Ltd. News and Updates

Keep track of all breaking news on Glenmark Pharmaceuticals Ltd. from all sources in a single place.

Load latest
Is Glenmark Pharmaceuticals Ltd. worth buying?
571 Votes:
Buy 79.33%
Sell 13.66%
Hold 7.01%
BUY
SELL
HOLD